Candida - diet, plant-based treatment... What is mycoplasmosis?

Candida albicans is a species of fungus responsible for the development of candidiasis. Interestingly, this pathogenic yeast is physiologically present in our skin and digestive tract. Candida develops most often as a result of the degradation of immunity caused by antibiotic use, which leads to a disturbance of its microbiota. Additionally, the risk factors include the use of immunosuppressive drugs (immunosuppressants), vitamin deficiencies, alcoholism, hormonal disorders, obesity and diabetes mellitus.

Infections caused by the opportunistic yeast *Candida albicans* can affect individuals across all age groups and health statuses, manifesting as either localized mucosal overgrowth or systemic dissemination in immunocompromised hosts. The cornerstone of managing suspected candidiasis remains an immediate consultation with a healthcare provider, who can prescribe an individualized pharmacological regimen tailored to the infection’s severity and the patient’s clinical profile. Nevertheless, a growing body of clinical evidence and mechanistic research suggests that strategic dietary modifications may serve as a valuable adjunctive measure—both in mitigating acute symptoms and in preventing recurrent episodes. The foundational principle of an anti-*Candida* dietary protocol centers on the stringent restriction of foods rich in monosaccharides and disaccharides—readily fermentable carbohydrates that *C. albicans* metabolizes with exceptional efficiency to fuel its proliferative expansion and biofilm formation. This metabolic predilection is exacerbated by the fact that elevated blood glucose levels, whether chronic (as in diabetes mellitus) or transient (postprandial spikes), impair local immune surveillance within mucosal tissues, thereby creating an immunologically permissive environment for fungal colonization. While the current medical literature does not yet provide definitive consensus on the causal relationship between high-sugar diets and candidiasis incidence, several systematic reviews have identified a statistically significant association between excessive intake of refined sugars and an increased susceptibility to *Candida* overgrowth, particularly among individuals with underlying metabolic dysregulations (e.g., insulin resistance or dysbiosis). Clinical dietary guidelines thus advocate for the elimination or substantial reduction of high-glycemic fruits (in both fresh and dried forms), as well as refined grain products derived from white flour (including commercial bread, pasta from soft wheat, and polished rice). Another critical predisposing factor for *Candida* proliferation is antibiotic-induced disruption of the gut microbiota—a common consequence of broad-spectrum antimicrobial therapy, which indiscriminately eradicates pathogenic bacteria while collateral damage extends to commensal species essential for intestinal homeostasis. The resultant dysbiosis compromises epithelial barrier integrity and facilitates fungal adhesion to mucosal surfaces. In this context, probiotics emerge as a therapeutic cornerstone, available either as supplemental formulations or through naturally fermented foods such as live-culture yogurts (containing strains like *Lactobacillus rhamnosus* or *Bifidobacterium*), kefir, buttermilk, and lacto-fermented vegetables (e.g., sauerkraut and pickled cucumbers). Robust *in vitro* and *in vivo* data demonstrate that probiotic administration can attenuate *Candida* colonization via multiple mechanisms: competitive exclusion through niche occupation, enhancement of host immune responses (e.g., stimulation of IgA secretion and macrophage activity), and restoration of gut barrier function. Notably, the efficacy of probiotic intervention has been substantiated in both prophylactic settings and as a complementary strategy to conventional antifungal treatments, particularly in patients prone to recurrent infections or those with compromised immune defenses.

Beyond dietary modifications, the strategic incorporation of specific herbs and spices plays a pivotal role in the management of *Candida*-related fungal overgrowth. Of particular note are common garlic (*Allium sativum*) and turmeric (*Curcuma longa*), both of which have been extensively studied for their antifungal properties. In the case of garlic, the primary bioactive constituent is allicin—a sulfur-containing compound with well-documented fungistatic effects. Rodent model studies have demonstrated its capacity to inhibit the proliferation of pathogenic *Candida* strains; however, it is critical to acknowledge that the natural allicin content in raw garlic is negligible compared to the therapeutic concentrations employed in experimental settings. Thus, while garlic may serve as a valuable adjunct in preventive strategies, its standalone consumption is unlikely to achieve complete eradication of an established infection. Conversely, curcumin—the principal polyphenolic compound found in turmeric rhizomes—exhibits substantially greater antifungal potency, as evidenced by *in vitro* research wherein curcumin not only suppressed the replication of *Candida albicans* but also induced apoptotic cell death in fungal populations. Supplemental formulations such as *Candida Support* frequently leverage the synergistic effects of botanical extracts. Despite encouraging findings from *in vivo* and *in vitro* investigations, the impact of dietary interventions on the pathogenesis of *Candida albicans* in human subjects remains a subject of ongoing scientific debate. Although numerous publications suggest potential benefits from reducing simple sugar intake or introducing probiotic regimens, there remains a paucity of large-scale, randomized clinical trials with sufficient statistical power to definitively validate the efficacy of these approaches in patients diagnosed with candidiasis.